"In France, all the fundamentals are in place to ensure the success of Life Sciences real estate.

Established as an asset class in its own right in the USA and, albeit to a lesser extent, in the UK, Life Sciences real estate remains a niche sector on the French market. As a new cluster begins to emerge around the Institut Gustave-Roussy, within the ZAC Campus Grand Parc in Villejuif, Nicolas Verdillon, Director of Investments France at CBRE, and his colleague Pierre-Édouard Boudot, Senior Director of the Studies and Research Department, talk to Business Immo Global about this still nascent asset class and the promise it holds for real estate investors in France.